Table 1B.
Oceania region countries: COVID-19 cases and deaths (data from 2 May 2021), data on the number of children screened and diseases included, and the overall impact of COVID-19 pandemic on newborn screening. Legend: N/A - The question was not answered.
| Country (region) | Population (in millions) | COVID-19 cases per million (in thousands) | Deaths due to COVID-19 (per million) |
Wave with more impact on the country | Wave with more impact on NBS | Average number of newborns per country (2015–2020; from 30 June of the initial and final year) | Newborns screened/year/centre | Number of diseases in NBS | Impairment of NBS during the pandemic* | Were there plans/guidelines for NBS during a pandemic |
| Oceania | ||||||||||
| Australia (Victoria) | 25.8 | 1.2 | 35 | Second | Second | 318 314 | 80 000 | 21–30 | None | No |
| Australia (New South Wales) | 25.8 | 1.2 | 35 | First | First | 318 314 | 100 000 | 31 or more | Little | No |
| New Zealand (Auckland) |
5.0 | 0.5 | 5 | Both equally | First | 59 614 | 57 000 | 21–30 | Little | No |
*A 5-point Likert scale was used to determine the impairment (1=none, 2=little, 3=moderate, 4=a lot, 5=a great deal).
NBS, newborn screening.